CA2356532A1 - Noninvasive vascular therapy - Google Patents
Noninvasive vascular therapy Download PDFInfo
- Publication number
- CA2356532A1 CA2356532A1 CA002356532A CA2356532A CA2356532A1 CA 2356532 A1 CA2356532 A1 CA 2356532A1 CA 002356532 A CA002356532 A CA 002356532A CA 2356532 A CA2356532 A CA 2356532A CA 2356532 A1 CA2356532 A1 CA 2356532A1
- Authority
- CA
- Canada
- Prior art keywords
- light
- photosensitizing agent
- subject
- lesion
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002792 vascular Effects 0.000 title claims abstract description 14
- 238000002560 therapeutic procedure Methods 0.000 title description 12
- 239000003504 photosensitizing agent Substances 0.000 claims abstract description 109
- 238000000034 method Methods 0.000 claims abstract description 72
- 210000001519 tissue Anatomy 0.000 claims abstract description 58
- 238000002428 photodynamic therapy Methods 0.000 claims abstract description 47
- 230000003902 lesion Effects 0.000 claims abstract description 39
- 239000000651 prodrug Substances 0.000 claims abstract description 39
- 229940002612 prodrug Drugs 0.000 claims abstract description 39
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 28
- 230000004913 activation Effects 0.000 claims abstract description 17
- 230000001678 irradiating effect Effects 0.000 claims abstract description 16
- 230000003511 endothelial effect Effects 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 52
- 239000000427 antigen Substances 0.000 claims description 29
- 102000036639 antigens Human genes 0.000 claims description 29
- 108091007433 antigens Proteins 0.000 claims description 29
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 claims description 17
- 229960004657 indocyanine green Drugs 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 12
- 239000013307 optical fiber Substances 0.000 claims description 12
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims description 10
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 9
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 9
- 229960002749 aminolevulinic acid Drugs 0.000 claims description 8
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims description 6
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 6
- 206010033675 panniculitis Diseases 0.000 claims description 5
- 210000004304 subcutaneous tissue Anatomy 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 239000002502 liposome Substances 0.000 claims description 4
- 230000035515 penetration Effects 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 2
- 229920000620 organic polymer Polymers 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 230000020169 heat generation Effects 0.000 claims 1
- WIQKYZYFTAEWBF-UHFFFAOYSA-L motexafin lutetium hydrate Chemical compound O.[Lu+3].CC([O-])=O.CC([O-])=O.C1=C([N-]2)C(CC)=C(CC)C2=CC(C(=C2C)CCCO)=NC2=CN=C2C=C(OCCOCCOCCOC)C(OCCOCCOCCOC)=CC2=NC=C2C(C)=C(CCCO)C1=N2 WIQKYZYFTAEWBF-UHFFFAOYSA-L 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 16
- 150000001875 compounds Chemical class 0.000 abstract description 13
- 238000011282 treatment Methods 0.000 abstract description 12
- 230000002159 abnormal effect Effects 0.000 abstract description 11
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000001185 bone marrow Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 210000003563 lymphoid tissue Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 29
- 210000003491 skin Anatomy 0.000 description 28
- 241001465754 Metazoa Species 0.000 description 19
- 230000005855 radiation Effects 0.000 description 17
- 230000001235 sensitizing effect Effects 0.000 description 15
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 14
- 208000034827 Neointima Diseases 0.000 description 13
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 12
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 12
- 230000006378 damage Effects 0.000 description 12
- 210000002744 extracellular matrix Anatomy 0.000 description 12
- 239000003446 ligand Substances 0.000 description 11
- 231100000216 vascular lesion Toxicity 0.000 description 11
- 230000002186 photoactivation Effects 0.000 description 9
- 230000008685 targeting Effects 0.000 description 9
- 150000004032 porphyrins Chemical class 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000003013 cytotoxicity Effects 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 230000002035 prolonged effect Effects 0.000 description 6
- 230000000451 tissue damage Effects 0.000 description 6
- 231100000827 tissue damage Toxicity 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000036765 blood level Effects 0.000 description 5
- 150000004035 chlorins Chemical class 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- 229950003937 tolonium Drugs 0.000 description 5
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 5
- 102000005862 Angiotensin II Human genes 0.000 description 4
- 101800000733 Angiotensin-2 Proteins 0.000 description 4
- 206010073306 Exposure to radiation Diseases 0.000 description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 4
- 229950006323 angiotensin ii Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960002897 heparin Drugs 0.000 description 4
- 229920000669 heparin Polymers 0.000 description 4
- 230000001771 impaired effect Effects 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- -1 Photophrin~ (QLT Chemical class 0.000 description 3
- 206010034972 Photosensitivity reaction Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000000886 photobiology Effects 0.000 description 3
- 230000036211 photosensitivity Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 229950003776 protoporphyrin Drugs 0.000 description 3
- 208000037803 restenosis Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- MHIITNFQDPFSES-UHFFFAOYSA-N 25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1(25),2,4,6,8(27),9,11,13,15,17,19,21,23-tridecaene Chemical class N1C(C=C2C3=CC=CC=C3C(C=C3NC(=C4)C=C3)=N2)=CC=C1C=C1C=CC4=N1 MHIITNFQDPFSES-UHFFFAOYSA-N 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000018262 Peripheral vascular disease Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000001028 anti-proliverative effect Effects 0.000 description 2
- 150000004036 bacteriochlorins Chemical class 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000002165 photosensitisation Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- BBNQQADTFFCFGB-UHFFFAOYSA-N purpurin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC(O)=C3C(=O)C2=C1 BBNQQADTFFCFGB-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
- UZFPOOOQHWICKY-UHFFFAOYSA-N 3-[13-[1-[1-[8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21,24-dihydroporphyrin-2-yl]ethoxy]ethyl]-18-(2-carboxyethyl)-8-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid Chemical compound N1C(C=C2C(=C(CCC(O)=O)C(C=C3C(=C(C)C(C=C4N5)=N3)CCC(O)=O)=N2)C)=C(C)C(C(C)O)=C1C=C5C(C)=C4C(C)OC(C)C1=C(N2)C=C(N3)C(C)=C(C(O)C)C3=CC(C(C)=C3CCC(O)=O)=NC3=CC(C(CCC(O)=O)=C3C)=NC3=CC2=C1C UZFPOOOQHWICKY-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical compound C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 229960003569 hematoporphyrin Drugs 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000002977 hyperthermial effect Effects 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 108010021336 lanreotide Proteins 0.000 description 1
- 229960002437 lanreotide Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- RTGDFNSFWBGLEC-SYZQJQIISA-N mycophenolate mofetil Chemical compound COC1=C(C)C=2COC(=O)C=2C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1 RTGDFNSFWBGLEC-SYZQJQIISA-N 0.000 description 1
- 229960004866 mycophenolate mofetil Drugs 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000079 pharmacotherapeutic effect Effects 0.000 description 1
- 238000001782 photodegradation Methods 0.000 description 1
- 238000005362 photophoresis Methods 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 231100000760 phototoxic Toxicity 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229960004293 porfimer sodium Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 229910052713 technetium Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-UHFFFAOYSA-N technetium atom Chemical compound [Tc] GKLVYJBZJHMRIY-UHFFFAOYSA-N 0.000 description 1
- 229960002197 temoporfin Drugs 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N2005/0602—Apparatus for use inside the body for treatment of blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0604—Lungs and/or airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0609—Stomach and/or esophagus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Electromagnetism (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11623599P | 1999-01-15 | 1999-01-15 | |
| US60/116,235 | 1999-01-15 | ||
| PCT/US2000/000852 WO2000041726A2 (en) | 1999-01-15 | 2000-01-14 | Noninvasive vascular therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2356532A1 true CA2356532A1 (en) | 2000-07-20 |
Family
ID=22366011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002356532A Abandoned CA2356532A1 (en) | 1999-01-15 | 2000-01-14 | Noninvasive vascular therapy |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7767208B2 (enExample) |
| EP (1) | EP1131099A2 (enExample) |
| JP (1) | JP2002534218A (enExample) |
| AU (1) | AU2412800A (enExample) |
| CA (1) | CA2356532A1 (enExample) |
| WO (1) | WO2000041726A2 (enExample) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2329756A (en) | 1997-09-25 | 1999-03-31 | Univ Bristol | Assemblies of light emitting diodes |
| US6200134B1 (en) | 1998-01-20 | 2001-03-13 | Kerr Corporation | Apparatus and method for curing materials with radiation |
| US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
| US9192780B2 (en) * | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
| US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US6602274B1 (en) | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
| EP1131099A2 (en) | 1999-01-15 | 2001-09-12 | Light Sciences Corporation | Noninvasive vascular therapy |
| US6454789B1 (en) | 1999-01-15 | 2002-09-24 | Light Science Corporation | Patient portable device for photodynamic therapy |
| US6217848B1 (en) * | 1999-05-20 | 2001-04-17 | Mallinckrodt Inc. | Cyanine and indocyanine dye bioconjugates for biomedical applications |
| US6944493B2 (en) | 1999-09-10 | 2005-09-13 | Akora, Inc. | Indocyanine green (ICG) compositions and related methods of use |
| WO2001017561A1 (en) * | 1999-09-10 | 2001-03-15 | Akorn, Inc. | Fluorescent dye angiography and dye-enhanced photocoagulation |
| US6351663B1 (en) | 1999-09-10 | 2002-02-26 | Akorn, Inc. | Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation |
| US6443976B1 (en) | 1999-11-30 | 2002-09-03 | Akorn, Inc. | Methods for treating conditions and illnesses associated with abnormal vasculature |
| US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
| EP1267935A2 (en) | 2000-01-12 | 2003-01-02 | Light Sciences Corporation | Novel treatment for eye disease |
| US7320593B2 (en) | 2000-03-08 | 2008-01-22 | Tir Systems Ltd. | Light emitting diode light source for curing dental composites |
| JP2002241307A (ja) * | 2001-02-19 | 2002-08-28 | Yasuhiko Tabata | 光増感剤を含有する超音波治療用活性酸素発生剤 |
| GB0127581D0 (en) * | 2001-11-17 | 2002-01-09 | Univ St Andrews | Therapeutic Light-emitting device |
| US8086296B2 (en) * | 2002-04-30 | 2011-12-27 | Brainsonix Corporation | Methods for modifying electrical currents in neuronal circuits |
| US9592409B2 (en) | 2002-04-30 | 2017-03-14 | The Regents Of The University Of California | Methods for modifying electrical currents in neuronal circuits |
| AU2003248747A1 (en) | 2002-06-27 | 2004-01-19 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| EP1606291A2 (en) | 2002-07-02 | 2005-12-21 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its dervatives |
| WO2004011848A2 (en) | 2002-07-25 | 2004-02-05 | Dahm Jonathan S | Method and apparatus for using light emitting diodes for curing |
| US7182597B2 (en) | 2002-08-08 | 2007-02-27 | Kerr Corporation | Curing light instrument |
| AU2003298561A1 (en) | 2002-08-23 | 2004-05-13 | Jonathan S. Dahm | Method and apparatus for using light emitting diodes |
| CN2885311Y (zh) | 2006-01-18 | 2007-04-04 | 郑成福 | 经尿道光动力疗法前列腺治疗仪 |
| US20080269846A1 (en) * | 2003-03-14 | 2008-10-30 | Light Sciences Oncology, Inc. | Device for treatment of blood vessels using light |
| US10376711B2 (en) | 2003-03-14 | 2019-08-13 | Light Sciences Oncology Inc. | Light generating guide wire for intravascular use |
| JP2006522660A (ja) * | 2003-04-10 | 2006-10-05 | ライト バイオサイエンス，エルエルシー | 細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置 |
| US7220778B2 (en) * | 2003-04-15 | 2007-05-22 | The General Hospital Corporation | Methods and devices for epithelial protection during photodynamic therapy |
| US7659301B2 (en) * | 2003-04-15 | 2010-02-09 | The General Hospital Corporation | Methods and devices for epithelial protection during photodynamic therapy |
| CN101247768A (zh) | 2003-07-31 | 2008-08-20 | 莱特生物科学有限公司 | 用于光动力学治疗烧伤、创伤和相关皮肤病的系统和方法 |
| US7553326B2 (en) * | 2003-11-24 | 2009-06-30 | Sweet Richard M | Method and apparatus for preventing dialysis graft intimal hyperplasia |
| ATE553505T1 (de) | 2004-06-15 | 2012-04-15 | Data Cloak Llc | Elektro-optische hochleistungs-led-anordnung |
| RU2297859C1 (ru) * | 2005-10-11 | 2007-04-27 | Федеральное Государственное Учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию | Способ лечения диссеминированных форм меланомы |
| WO2009003173A1 (en) * | 2007-06-27 | 2008-12-31 | The General Hospital Corporation | Method and apparatus for optical inhibition of photodymanic therapy |
| EP2197546A1 (en) * | 2007-09-14 | 2010-06-23 | Light Sciences Oncology, Inc. | Systems, devices, and methods for photoactive assisted resection |
| KR20110016940A (ko) * | 2008-05-15 | 2011-02-18 | 세람옵텍 인더스트리스, 인크. | 경피성 혈관 치료에 대한 방법 및 장치 |
| US9066777B2 (en) | 2009-04-02 | 2015-06-30 | Kerr Corporation | Curing light device |
| US9072572B2 (en) | 2009-04-02 | 2015-07-07 | Kerr Corporation | Dental light device |
| US8465471B2 (en) | 2009-08-05 | 2013-06-18 | Rocin Laboratories, Inc. | Endoscopically-guided electro-cauterizing power-assisted fat aspiration system for aspirating visceral fat tissue within the abdomen of a patient |
| US20110213336A1 (en) | 2009-08-05 | 2011-09-01 | Cucin Robert L | Method of and apparatus for sampling, processing and collecting tissue and reinjecting the same into human patients |
| US8348929B2 (en) | 2009-08-05 | 2013-01-08 | Rocin Laboratories, Inc. | Endoscopically-guided tissue aspiration system for safely removing fat tissue from a patient |
| US20110282334A1 (en) * | 2010-05-11 | 2011-11-17 | Ceramoptec Industries Inc. | Device and method for fistula treatment |
| AU2011301981A1 (en) * | 2010-09-16 | 2013-04-04 | Case Western Reserve University | Photodynamic therapy system, device and associated method of treatment |
| WO2013051732A1 (ja) | 2011-10-07 | 2013-04-11 | 国立大学法人鳥取大学 | リポソーム複合体 |
| US20150087685A1 (en) * | 2012-04-13 | 2015-03-26 | Nitto Denko Corporation | Phototherapy Devices and Methods Comprising Optionally Substituted Quinquiesphenyl Compounds |
| JP6347910B2 (ja) * | 2012-04-27 | 2018-06-27 | 国立大学法人鳥取大学 | 近赤外線の波長特性を利用した非侵襲性医療装置 |
| US9950188B2 (en) * | 2012-05-31 | 2018-04-24 | Color Seven Co., Ltd. | Apparatus for relaxing smooth muscles of human body |
| US9061133B2 (en) | 2012-12-27 | 2015-06-23 | Brainsonix Corporation | Focused ultrasonic transducer navigation system |
| US10512794B2 (en) | 2016-12-16 | 2019-12-24 | Brainsonix Corporation | Stereotactic frame |
| US10974078B2 (en) | 2012-12-27 | 2021-04-13 | Brainsonix Corporation | Treating degenerative dementia with low intensity focused ultrasound pulsation (LIFUP) device |
| CA2900038C (en) | 2013-02-07 | 2021-02-09 | Rocomp Global, Llc | Electromagnetic radiation targeting devices, assemblies, systems and methods |
| MX2016000022A (es) * | 2013-07-03 | 2016-10-31 | Uvlrx Therapeutix Inc | Sistemas y metodos para la irradiacion in vivo de la sangre. |
| EP3851161A1 (en) | 2015-10-15 | 2021-07-21 | DUSA Pharmaceuticals, Inc. | Adjustable illuminator for photodynamic therapy and diagnosis |
| US10357567B1 (en) | 2018-01-12 | 2019-07-23 | Dusa Pharmaceuticals, Inc. | Methods for photodynamic therapy |
| CN108379603A (zh) * | 2018-03-05 | 2018-08-10 | 田耘博 | 一种超声波血浆病毒灭活方法及系统 |
| US11759661B2 (en) | 2020-05-20 | 2023-09-19 | Brainsonix Corporation | Ultrasonic transducer treatment device |
| US11529153B2 (en) | 2020-08-21 | 2022-12-20 | University Of Washington | Vaccine generation |
| WO2022040258A1 (en) | 2020-08-21 | 2022-02-24 | University Of Washington | Disinfection method and apparatus |
| US12257446B2 (en) | 2020-08-24 | 2025-03-25 | Brainsonix Corporation | Systems and methods for neuromodulation of neuronal circuits using transcranial focused microwave pulses |
| US11425905B2 (en) | 2020-09-02 | 2022-08-30 | University Of Washington | Antimicrobial preventive netting |
| US11458220B2 (en) | 2020-11-12 | 2022-10-04 | Singletto Inc. | Microbial disinfection for personal protection equipment |
| JPWO2023210645A1 (enExample) | 2022-04-27 | 2023-11-02 | ||
| US12359369B2 (en) | 2022-08-11 | 2025-07-15 | Singletto Inc. | Skin protection against microbial particles |
Family Cites Families (211)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US114434A (en) * | 1871-05-02 | Improvement in dry-earth closets | ||
| US127230A (en) * | 1872-05-28 | Improvement in lamp-chimney cleaners | ||
| US87205A (en) * | 1869-02-23 | Improved velocipede | ||
| US49247A (en) * | 1865-08-08 | Improvement in the manufacture of pyroligneous acid | ||
| US127224A (en) * | 1872-05-28 | Improvement in cotton-seed cleaners | ||
| JPS5384998U (enExample) | 1976-12-15 | 1978-07-13 | ||
| US4337759A (en) | 1979-10-10 | 1982-07-06 | John M. Popovich | Radiant energy concentration by optical total internal reflection |
| JPS57185220U (enExample) | 1981-05-21 | 1982-11-25 | ||
| US4649151A (en) | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
| US4577636A (en) | 1982-11-23 | 1986-03-25 | The Beth Israel Hospital Association | Method for diagnosis of atherosclerosis |
| US4675338A (en) | 1984-07-18 | 1987-06-23 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
| US4693885A (en) | 1984-07-18 | 1987-09-15 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
| US4690492A (en) | 1984-09-04 | 1987-09-01 | Oximetrix, Inc. | Optical coupling |
| WO1986001720A1 (en) * | 1984-09-13 | 1986-03-27 | Cytogen Corporation | Antibody therapeutic agent conjugates |
| US4753958A (en) | 1985-02-07 | 1988-06-28 | University Of Cal | Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins |
| US4693556A (en) | 1985-06-04 | 1987-09-15 | Laser Therapeutics, Inc. | Apparatus for producing a spherical pattern of light and method of manufacture |
| KR910009202B1 (ko) | 1985-10-23 | 1991-11-04 | 니혼메디피직스 가부시끼가이샤 | 포르피린 유도체의 제조방법 |
| US5534506A (en) | 1986-01-02 | 1996-07-09 | University Of Toledo | Use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
| US5811248A (en) * | 1986-03-31 | 1998-09-22 | Charter Ventures | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| US4916070A (en) * | 1986-04-14 | 1990-04-10 | The General Hospital Corporation | Fibrin-specific antibodies and method of screening for the antibodies |
| US4861876A (en) | 1986-11-26 | 1989-08-29 | Wayne State University | Hematoporphyrin derivative and method of preparation and purification |
| US5494793A (en) | 1986-12-15 | 1996-02-27 | British Technology Group Usa Inc. | Monomeric phthalocyanine reagents |
| US5283255A (en) | 1987-01-20 | 1994-02-01 | The University Of British Columbia | Wavelength-specific cytotoxic agents |
| US5095030A (en) | 1987-01-20 | 1992-03-10 | University Of British Columbia | Wavelength-specific cytotoxic agents |
| US5171749A (en) * | 1987-01-20 | 1992-12-15 | University Of British Columbia | Wavelength-specific cytotoxic agents |
| US4878891A (en) | 1987-06-25 | 1989-11-07 | Baylor Research Foundation | Method for eradicating infectious biological contaminants in body tissues |
| US4957481A (en) | 1987-10-01 | 1990-09-18 | U.S. Bioscience | Photodynamic therapeutic technique |
| US5259380A (en) | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
| US4852567A (en) | 1988-01-21 | 1989-08-01 | C. R. Bard, Inc. | Laser tipped catheter |
| US4823244A (en) | 1988-01-29 | 1989-04-18 | Niagara Medical Innovations Inc. | Light source assembly |
| US5026367A (en) | 1988-03-18 | 1991-06-25 | Cardiovascular Laser Systems, Inc. | Laser angioplasty catheter and a method for use thereof |
| US4907132A (en) * | 1988-03-22 | 1990-03-06 | Lumitex, Inc. | Light emitting panel assemblies and method of making same |
| US5053006A (en) | 1988-04-19 | 1991-10-01 | Watson Brant D | Method for the permanent occlusion of arteries |
| US4925736A (en) | 1988-07-06 | 1990-05-15 | Long Island Jewish Medical Center | Topical hematoporphyrin |
| US5002962A (en) | 1988-07-20 | 1991-03-26 | Health Research, Inc. | Photosensitizing agents |
| US5198460A (en) | 1988-07-20 | 1993-03-30 | Health Research Inc. | Pyropheophorbides and their use in photodynamic therapy |
| US4998930A (en) | 1988-08-03 | 1991-03-12 | Phototherapeutic Systems | Intracavity laser phototherapy method |
| EP0386241A4 (en) | 1988-08-23 | 1990-10-03 | Radiotech Inst An | Light-guiding device for medical treatment |
| US5028594A (en) | 1988-12-27 | 1991-07-02 | Naxcor | Use of photodynamic compositions for cytotoxic effects |
| US5284869A (en) * | 1991-12-17 | 1994-02-08 | Emil Bisaccia | Photophoresis methods for treating atherosclerosis and for preventing restenosis following angioplasty |
| US5048524A (en) | 1989-03-03 | 1991-09-17 | Camino Laboratories, Inc. | Blood parameter measurement |
| US4935498A (en) | 1989-03-06 | 1990-06-19 | Board Of Regents, The University Of Texas System | Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles |
| US5041078A (en) | 1989-03-06 | 1991-08-20 | Baylor Research Foundation, A Nonprofit Corporation Of The State Of Texas | Photodynamic viral deactivation with sapphyrins |
| US5112946A (en) * | 1989-07-06 | 1992-05-12 | Repligen Corporation | Modified pf4 compositions and methods of use |
| JPH03128576A (ja) | 1989-07-07 | 1991-05-31 | Konica Corp | 画像読取装置 |
| US4973848A (en) | 1989-07-28 | 1990-11-27 | J. Mccaughan | Laser apparatus for concurrent analysis and treatment |
| US4997639A (en) | 1989-11-27 | 1991-03-05 | Nippon Petrochemicals Company, Limited | Method for detecting cholesterol deposited in bodies of mammals |
| US5543514A (en) | 1989-12-21 | 1996-08-06 | Board Of Regents, The University Of Texas System | Water-soluble sapphyrins |
| US5594136A (en) | 1989-12-21 | 1997-01-14 | Pharmacyclics, Inc. | Texaphyrin solid supports and devices |
| EP0510007B1 (en) | 1990-01-08 | 1996-05-08 | Health Research, Inc. | A submersible lens fiberoptic assembly |
| GB9014307D0 (en) | 1990-06-27 | 1990-08-15 | Scient Generics Ltd | Method of treatment and compositions therefor |
| US5484778C1 (en) | 1990-07-17 | 2001-05-08 | Univ Cleveland Hospitals | Phthalocynine photosensitizers for photodynamic therapy and methods for their use |
| US5549660A (en) | 1990-11-15 | 1996-08-27 | Amron, Ltd. | Method of treating acne |
| US5500009A (en) | 1990-11-15 | 1996-03-19 | Amron, Ltd. | Method of treating herpes |
| JP3154742B2 (ja) | 1991-04-30 | 2001-04-09 | 日本石油化学株式会社 | 哺乳類の動脈硬化症治療剤 |
| ES2110002T3 (es) | 1991-06-21 | 1998-02-01 | Baxter Int | Procedimiento de inactivacion de agentes patogenos en fluidos corporales. |
| US5769844A (en) | 1991-06-26 | 1998-06-23 | Ghaffari; Shahriar | Conventional light-pumped high power system for medical applications |
| US5263925A (en) | 1991-07-22 | 1993-11-23 | Gilmore Jr Thomas F | Photopheresis blood treatment |
| US5770592A (en) | 1991-11-22 | 1998-06-23 | Alcon Laboratories, Inc. | Prevention and treatment of ocular neovascularization using angiostatic steroids |
| IL100545A (en) | 1991-12-29 | 1995-03-15 | Dimotech Ltd | Photodynamic Healing Therapy Device |
| US5565552A (en) | 1992-01-21 | 1996-10-15 | Pharmacyclics, Inc. | Method of expanded porphyrin-oligonucleotide conjugate synthesis |
| US5330741A (en) | 1992-02-24 | 1994-07-19 | The Regents Of The University Of California | Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors |
| US5776427A (en) | 1992-03-05 | 1998-07-07 | Board Of Regents, The University Of Texas System | Methods for targeting the vasculature of solid tumors |
| US5965132A (en) | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
| CA2131528C (en) | 1992-03-05 | 2004-07-13 | Philip E. Thorpe | Methods and compositions for targeting the vasculature of solid tumors |
| US5474765A (en) | 1992-03-23 | 1995-12-12 | Ut Sw Medical Ctr At Dallas | Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells |
| US5655832A (en) | 1992-04-16 | 1997-08-12 | Tir Technologies, Inc. | Multiple wavelength light processor |
| US5776966A (en) | 1992-05-27 | 1998-07-07 | University Of British Columbia | Selective cell inactivation in blood |
| US5807881A (en) | 1992-05-27 | 1998-09-15 | Quadra Logic Technologies, Inc. | Method for selectively reducing activated leukocyte cell population |
| US5976535A (en) | 1992-06-09 | 1999-11-02 | Neorx Corporation | Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore |
| US6217869B1 (en) | 1992-06-09 | 2001-04-17 | Neorx Corporation | Pretargeting methods and compounds |
| DE69331319T2 (de) | 1992-06-09 | 2002-08-08 | Neorx Corp., Seattle | Biotin-DOTA Konjugate und deren Verwendung in "Pretargeting" Verfahren |
| US5298018A (en) | 1992-08-14 | 1994-03-29 | Pdt Cardiovascular, Inc. | Method for treating cardiovascular disease through adjunctive photodynamic therapy |
| DE4228389C2 (de) * | 1992-08-26 | 1994-07-21 | Kuebler Gmbh Dr | Gewinnung und Kultivierung transformierter Zellen |
| EP0660712B1 (en) | 1992-09-21 | 2001-05-30 | Quadra Logic Technologies Inc. | Transcutaneous in vivo activation of photosensitive agents in blood |
| GB2272278B (en) | 1992-10-23 | 1997-04-09 | Cancer Res Campaign Tech | Light source |
| US5700243A (en) | 1992-10-30 | 1997-12-23 | Pdt Systems, Inc. | Balloon perfusion catheter |
| FI952436L (fi) * | 1992-11-20 | 1995-07-05 | Univ British Columbia | Menetelmä valoherkkien aineiden aktivoimiseksi |
| US5368841A (en) | 1993-02-11 | 1994-11-29 | The General Hospital Corporation | Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides |
| JP3565442B2 (ja) | 1993-04-22 | 2004-09-15 | 新日本石油化学株式会社 | 哺乳類の関節炎の診断剤および／または治療剤 |
| US5482698A (en) | 1993-04-22 | 1996-01-09 | Immunomedics, Inc. | Detection and therapy of lesions with biotin/avidin polymer conjugates |
| US5445608A (en) | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
| US5420768A (en) | 1993-09-13 | 1995-05-30 | Kennedy; John | Portable led photocuring device |
| US5514669A (en) | 1993-09-29 | 1996-05-07 | Medical College Of Ohio | Use of photodynamic therapy to treat prostatic tissue |
| US5454794A (en) | 1993-10-15 | 1995-10-03 | Pdt Systems, Inc. | Steerable light diffusing catheter |
| US5441531A (en) | 1993-10-18 | 1995-08-15 | Dusa Pharmaceuticals Inc. | Illuminator and methods for photodynamic therapy |
| US5913834A (en) | 1993-11-04 | 1999-06-22 | Francais; Caramia | System for imparting sensory effects across a mother's abdomen to a fetus and monitoring effects on the fetus |
| US6015897A (en) | 1993-12-07 | 2000-01-18 | Neorx Corporation | Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota |
| DE69433343D1 (de) * | 1993-12-07 | 2003-12-24 | Neorx Corp | Pretargeting verfahren und mitteln |
| IL108918A (en) | 1994-03-10 | 1997-04-15 | Medic Lightech Ltd | Apparatus for efficient photodynamic treatment |
| US5798349A (en) | 1994-03-14 | 1998-08-25 | The General Hospital Corporation | Use of green porphyrins to treat neovasculature in the eye |
| US5556612A (en) | 1994-03-15 | 1996-09-17 | The General Hospital Corporation | Methods for phototherapeutic treatment of proliferative skin diseases |
| US5851225A (en) | 1994-03-18 | 1998-12-22 | Spectra Science Corporation | Photoemitting catheters and other structures suitable for use in photo-dynamic therapy and other applications |
| US5474528A (en) | 1994-03-21 | 1995-12-12 | Dusa Pharmaceuticals, Inc. | Combination controller and patch for the photodynamic therapy of dermal lesion |
| US5989245A (en) | 1994-03-21 | 1999-11-23 | Prescott; Marvin A. | Method and apparatus for therapeutic laser treatment |
| US5616140A (en) | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
| DE69514262T2 (de) | 1994-03-23 | 2001-10-11 | Hamamatsu Photonics K.K., Hamamatsu | Katheter mit Lichtleitfaser |
| US5456661A (en) | 1994-03-31 | 1995-10-10 | Pdt Cardiovascular | Catheter with thermally stable balloon |
| US5498710A (en) | 1994-04-22 | 1996-03-12 | Health Research, Inc. | Alkyl ether analogues of benzoporphyrin derivatives |
| ITFI940095A1 (it) * | 1994-05-23 | 1995-11-23 | Molteni & C | Coniugati fotodinamici aventi proprieta' biocide |
| US5591847A (en) | 1994-05-23 | 1997-01-07 | Health Research, Inc. | Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages |
| US5519534A (en) | 1994-05-25 | 1996-05-21 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Irradiance attachment for an optical fiber to provide a uniform level of illumination across a plane |
| AU3374795A (en) | 1994-08-29 | 1996-03-22 | Prizm Pharmaceuticals, Inc. | Conjugates of vascular endothelial growth factor with targeted agents |
| US5698866A (en) | 1994-09-19 | 1997-12-16 | Pdt Systems, Inc. | Uniform illuminator for phototherapy |
| US5591855A (en) | 1994-10-14 | 1997-01-07 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| US5746494A (en) | 1994-11-22 | 1998-05-05 | Asahi Kogaku Kogyo Kabushiki Kaisha | Illuminating apparatus of endoscope |
| US6095147A (en) * | 1994-12-01 | 2000-08-01 | The Regents Of The University Of California | Method for photo-altering a biological system to improve biological effect |
| DE4445065A1 (de) | 1994-12-07 | 1996-06-13 | Diagnostikforschung Inst | Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung |
| US5882328A (en) | 1995-01-13 | 1999-03-16 | Qlt Phototherapeutics, Inc. | Method to prevent transplant rejection |
| US6107325A (en) | 1995-01-17 | 2000-08-22 | Qlt Phototherapeutics, Inc. | Green porphyrins as immunomodulators |
| US5643334A (en) | 1995-02-07 | 1997-07-01 | Esc Medical Systems Ltd. | Method and apparatus for the diagnostic and composite pulsed heating and photodynamic therapy treatment |
| NL9500495A (nl) | 1995-03-13 | 1996-10-01 | Cordis Europ | Balloncatheter met een enkel lumen en samenstel van een dergelijke catheter en een lichtgeleider. |
| US5686113A (en) | 1995-03-21 | 1997-11-11 | Temple University Of The Commonwealth System Of Higher Education | Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses |
| US5576013A (en) | 1995-03-21 | 1996-11-19 | Eastern Virginia Medical School | Treating vascular and neoplastic tissues |
| US5800432A (en) | 1995-05-01 | 1998-09-01 | Ep Technologies, Inc. | Systems and methods for actively cooling ablation electrodes using diodes |
| US5571152A (en) | 1995-05-26 | 1996-11-05 | Light Sciences Limited Partnership | Microminiature illuminator for administering photodynamic therapy |
| US5620439A (en) | 1995-06-06 | 1997-04-15 | George S. Abela | Catheter and technique for endovascular myocardial revascularization |
| JPH0947518A (ja) | 1995-06-26 | 1997-02-18 | Lederle Japan Ltd | フォトダイナミックセラピ用光ファイバレーザ導光プローブ |
| IT1275571B (it) | 1995-07-19 | 1997-08-07 | Consiglio Nazionale Ricerche | Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori |
| AU7237896A (en) | 1995-09-06 | 1997-03-27 | Research Foundation Of The State University Of New York, The | Two-photon upconverting dyes and applications |
| US5824080A (en) | 1995-09-28 | 1998-10-20 | The General Hospital Corporation | Photochemistry for the preparation of biologic grafts--allografts and xenografts |
| US5776175A (en) | 1995-09-29 | 1998-07-07 | Esc Medical Systems Ltd. | Method and apparatus for treatment of cancer using pulsed electromagnetic radiation |
| WO1997026885A1 (en) | 1996-01-23 | 1997-07-31 | The General Hospital Corporation Doing Business As Massachusetts General Hospital | Benzophenothiazine and benzoporphyrin dye combination photodynamic therapy of tumors |
| WO1997031582A1 (en) * | 1996-02-29 | 1997-09-04 | Cytopharm, Inc. | A novel phototherapeutic method for treating cancer and/or dermatological diseases and conditions |
| US5835648A (en) | 1996-03-07 | 1998-11-10 | Miravant Systems, Inc. | Surface illuminator for photodynamic therapy |
| US5800478A (en) | 1996-03-07 | 1998-09-01 | Light Sciences Limited Partnership | Flexible microcircuits for internal light therapy |
| IT1283218B1 (it) * | 1996-03-08 | 1998-04-16 | Bracco Spa | Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi |
| US5770730A (en) | 1996-03-08 | 1998-06-23 | Health Research, Inc. | Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer |
| US5952366A (en) | 1996-03-08 | 1999-09-14 | Health Research, Inc. | Alkyl ether analogs of chlorins having an N-substituted imide ring |
| WO1997033620A2 (de) * | 1996-03-15 | 1997-09-18 | Pulsion Verw. Gmbh & Co. Medical Systems Kg | Verbindungen zur behandlung von tumoren |
| NZ331977A (en) | 1996-03-26 | 2000-07-28 | Pharmacyclics Inc | Texaphyrin in photodynamic therapy of pigment-related lesions |
| ATE345682T1 (de) | 1996-05-01 | 2006-12-15 | Imarx Pharmaceutical Corp | In vitro verfahren zum einbringen von nukleinsäuren in eine zelle |
| US6013053A (en) | 1996-05-17 | 2000-01-11 | Qlt Photo Therapeutics Inc. | Balloon catheter for photodynamic therapy |
| AU727138B2 (en) * | 1996-06-04 | 2000-12-07 | Board Of Regents, The University Of Texas System | Membrane incorporation of texaphyrins |
| US5797868A (en) | 1996-07-25 | 1998-08-25 | Cordis Corporation | Photodynamic therapy balloon catheter |
| US5709653A (en) | 1996-07-25 | 1998-01-20 | Cordis Corporation | Photodynamic therapy balloon catheter with microporous membrane |
| AU3813897A (en) | 1996-07-25 | 1998-02-20 | Light Medicine, Inc. | Photodynamic therapy apparatus and methods |
| US5814008A (en) | 1996-07-29 | 1998-09-29 | Light Sciences Limited Partnership | Method and device for applying hyperthermia to enhance drug perfusion and efficacy of subsequent light therapy |
| AU3578497A (en) | 1996-08-08 | 1998-03-06 | Light Sciences Limited Partnership | Method and apparatus to treat gingival and periodontal disease |
| US5904147A (en) | 1996-08-16 | 1999-05-18 | University Of Massachusetts | Intravascular catheter and method of controlling hemorrhage during minimally invasive surgery |
| US5715837A (en) | 1996-08-29 | 1998-02-10 | Light Sciences Limited Partnership | Transcutaneous electromagnetic energy transfer |
| US5849027A (en) | 1996-09-04 | 1998-12-15 | Mbg Technologies, Inc. | Photodynamic therapy method and apparatus |
| US5913884A (en) | 1996-09-19 | 1999-06-22 | The General Hospital Corporation | Inhibition of fibrosis by photodynamic therapy |
| US5702432A (en) | 1996-10-03 | 1997-12-30 | Light Sciences Limited Partnership | Intracorporeal light treatment of blood |
| US5942534A (en) | 1996-10-10 | 1999-08-24 | The General Hospital Corporation | Photodynamic therapy for the treatment of osteoarthritis |
| GB9708265D0 (en) | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
| US5832931A (en) | 1996-10-30 | 1998-11-10 | Photogen, Inc. | Method for improved selectivity in photo-activation and detection of molecular diagnostic agents |
| US5829448A (en) | 1996-10-30 | 1998-11-03 | Photogen, Inc. | Method for improved selectivity in photo-activation of molecular agents |
| WO1998021581A1 (en) * | 1996-11-08 | 1998-05-22 | The Regents Of The University Of California | Methods and reagents for non-invasive imaging of atherosclerotic plaque |
| US5741316A (en) | 1996-12-02 | 1998-04-21 | Light Sciences Limited Partnership | Electromagnetic coil configurations for power transmission through tissue |
| US6080160A (en) | 1996-12-04 | 2000-06-27 | Light Sciences Limited Partnership | Use of shape memory alloy for internally fixing light emitting device at treatment site |
| US6021347A (en) | 1996-12-05 | 2000-02-01 | Herbst; Ewa | Electrochemical treatment of malignant tumors |
| US6063108A (en) | 1997-01-06 | 2000-05-16 | Salansky; Norman | Method and apparatus for localized low energy photon therapy (LEPT) |
| US5793781A (en) | 1997-01-24 | 1998-08-11 | Spectra Science Corporation | Solid state source for generating intense light for photodynamic therapy and photomedicine |
| US5997569A (en) | 1997-01-29 | 1999-12-07 | Light Sciences Limited Partnership | Flexible and adjustable grid for medical therapy |
| US5782896A (en) | 1997-01-29 | 1998-07-21 | Light Sciences Limited Partnership | Use of a shape memory alloy to modify the disposition of a device within an implantable medical probe |
| US5876427A (en) | 1997-01-29 | 1999-03-02 | Light Sciences Limited Partnership | Compact flexible circuit configuration |
| GB2323284B (en) | 1997-03-19 | 2001-01-03 | Rusch Mfg | Device for photodynamic therapy of pituitary tumours |
| US5817048A (en) | 1997-03-20 | 1998-10-06 | Brown University Research Foundation | Ultrasonic alternative to laser-based photodynamic therapy |
| US5827186A (en) | 1997-04-11 | 1998-10-27 | Light Sciences Limited Partnership | Method and PDT probe for minimizing CT and MRI image artifacts |
| US5957960A (en) | 1997-05-05 | 1999-09-28 | Light Sciences Limited Partnership | Internal two photon excitation device for delivery of PDT to diffuse abnormal cells |
| CA2284879C (en) | 1997-05-07 | 2005-10-25 | Qlt Phototherapeutics, Inc. | Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| IL120891A0 (en) | 1997-05-22 | 1997-09-30 | Technion Res & Dev Foundation | Photodynamic and sonodynamic therapy and agents for use therefor |
| US6100893A (en) | 1997-05-23 | 2000-08-08 | Light Sciences Limited Partnership | Constructing solid models using implicit functions defining connectivity relationships among layers of an object to be modeled |
| US5921244A (en) | 1997-06-11 | 1999-07-13 | Light Sciences Limited Partnership | Internal magnetic device to enhance drug therapy |
| US5766222A (en) | 1997-07-07 | 1998-06-16 | Petit; Michael G. | Nipple illuminator for photodynamic therapy |
| US6165440A (en) | 1997-07-09 | 2000-12-26 | Board Of Regents, The University Of Texas System | Radiation and nanoparticles for enhancement of drug delivery in solid tumors |
| US6058937A (en) | 1997-07-18 | 2000-05-09 | Miravant Systems, Inc. | Photodynamic Therapy of highly vascularized tissue |
| CA2298526A1 (en) | 1997-07-28 | 1999-02-04 | Dermatolazer Technologies Ltd | Phototherapy based method for treating pathogens and composition for effecting same |
| US6048359A (en) | 1997-08-25 | 2000-04-11 | Advanced Photodynamic Technologies, Inc. | Spatial orientation and light sources and method of using same for medical diagnosis and photodynamic therapy |
| US6180084B1 (en) * | 1998-08-25 | 2001-01-30 | The Burnham Institute | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same |
| US6183444B1 (en) | 1998-05-16 | 2001-02-06 | Microheart, Inc. | Drug delivery module |
| US6138681A (en) | 1997-10-13 | 2000-10-31 | Light Sciences Limited Partnership | Alignment of external medical device relative to implanted medical device |
| US5865840A (en) | 1997-10-22 | 1999-02-02 | Light Sciences Limited Partnership | Enhancement of light activation effect by immune augmentation |
| US6071944A (en) | 1997-11-12 | 2000-06-06 | Bowling Green State University | Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| US6123923A (en) | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
| US5945762A (en) | 1998-02-10 | 1999-08-31 | Light Sciences Limited Partnership | Movable magnet transmitter for inducing electrical current in an implanted coil |
| US20030030342A1 (en) | 1998-02-10 | 2003-02-13 | Chen James C. | Contactless energy transfer apparatus |
| US6331744B1 (en) | 1998-02-10 | 2001-12-18 | Light Sciences Corporation | Contactless energy transfer apparatus |
| US6281611B1 (en) | 1998-02-10 | 2001-08-28 | Light Sciences Corporation | Use of moving element to produce heat |
| US5997842A (en) | 1998-04-13 | 1999-12-07 | Light Sciences Limited Partnership | Radionuclide excited phosphorescent material for administering PDT |
| US6223071B1 (en) | 1998-05-01 | 2001-04-24 | Dusa Pharmaceuticals Inc. | Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light |
| WO1999058149A1 (en) | 1998-05-13 | 1999-11-18 | Light Sciences Limited Partnership | Controlled activation of targeted radionuclides |
| US6103751A (en) | 1998-06-22 | 2000-08-15 | Health Research, Inc. | Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents |
| US6416531B2 (en) | 1998-06-24 | 2002-07-09 | Light Sciences Corporation | Application of light at plural treatment sites within a tumor to increase the efficacy of light therapy |
| US6096066A (en) | 1998-09-11 | 2000-08-01 | Light Sciences Limited Partnership | Conformal patch for administering light therapy to subcutaneous tumors |
| GB9909763D0 (en) | 1998-09-12 | 1999-06-23 | Cehmcolloids Ltd | Cluring of resins |
| US6117862A (en) | 1998-10-09 | 2000-09-12 | Qlt, Inc. | Model and method for angiogenesis inhibition |
| US20010049502A1 (en) | 1998-11-25 | 2001-12-06 | Light Sciences Corporation | Guide sheath for repeated placement of a device |
| US6344050B1 (en) | 1998-12-21 | 2002-02-05 | Light Sciences Corporation | Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue |
| US6602274B1 (en) | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
| WO2000041725A2 (en) | 1999-01-15 | 2000-07-20 | Light Sciences Corporation | Therapeutic compositions for metabolic bone disorders or bone metastases |
| US6454789B1 (en) | 1999-01-15 | 2002-09-24 | Light Science Corporation | Patient portable device for photodynamic therapy |
| EP1131099A2 (en) | 1999-01-15 | 2001-09-12 | Light Sciences Corporation | Noninvasive vascular therapy |
| US6162242A (en) | 1999-01-21 | 2000-12-19 | Peyman; Gholam A. | Selective photodynamic treatment |
| DE19908426C2 (de) | 1999-02-26 | 2001-03-22 | Siemens Ag | Vertikalresonator-Laserdiode mit einer lichtabsorbierenden Schicht und Verfahren zu ihrer Herstellung |
| US6273904B1 (en) | 1999-03-02 | 2001-08-14 | Light Sciences Corporation | Polymer battery for internal light device |
| AU4139600A (en) | 1999-04-14 | 2000-11-14 | University Of British Columbia, The | 1,3-dipolar cycloadditions to polypyrrolic macrocycles |
| US6210425B1 (en) | 1999-07-08 | 2001-04-03 | Light Sciences Corporation | Combined imaging and PDT delivery system |
| US6238426B1 (en) | 1999-07-19 | 2001-05-29 | Light Sciences Corporation | Real-time monitoring of photodynamic therapy over an extended time |
| US20030114434A1 (en) | 1999-08-31 | 2003-06-19 | James Chen | Extended duration light activated cancer therapy |
| US6319273B1 (en) | 1999-12-16 | 2001-11-20 | Light Sciences Corporation | Illuminating device for treating eye disease |
| US6534040B2 (en) | 1999-12-23 | 2003-03-18 | Health Research, Inc. | Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| EP1267935A2 (en) | 2000-01-12 | 2003-01-02 | Light Sciences Corporation | Novel treatment for eye disease |
| US6624187B1 (en) | 2000-06-12 | 2003-09-23 | Health Research, Inc. | Long wave length absorbing bacteriochlorin alkyl ether analogs |
| US6520669B1 (en) | 2000-06-19 | 2003-02-18 | Light Sciences Corporation | Flexible substrate mounted solid-state light sources for exterior vehicular lighting |
| US6580228B1 (en) | 2000-08-22 | 2003-06-17 | Light Sciences Corporation | Flexible substrate mounted solid-state light sources for use in line current lamp sockets |
| US20020127224A1 (en) | 2001-03-02 | 2002-09-12 | James Chen | Use of photoluminescent nanoparticles for photodynamic therapy |
| WO2003061696A2 (en) | 2002-01-23 | 2003-07-31 | Light Sciences Corporation | Systems and methods for photodynamic therapy |
| AU2003248747A1 (en) | 2002-06-27 | 2004-01-19 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| EP1606291A2 (en) | 2002-07-02 | 2005-12-21 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its dervatives |
-
2000
- 2000-01-14 EP EP00902405A patent/EP1131099A2/en not_active Withdrawn
- 2000-01-14 AU AU24128/00A patent/AU2412800A/en not_active Abandoned
- 2000-01-14 CA CA002356532A patent/CA2356532A1/en not_active Abandoned
- 2000-01-14 JP JP2000593336A patent/JP2002534218A/ja active Pending
- 2000-01-14 WO PCT/US2000/000852 patent/WO2000041726A2/en not_active Ceased
-
2001
- 2001-07-13 US US09/905,777 patent/US7767208B2/en not_active Expired - Fee Related
-
2004
- 2004-07-26 US US10/899,834 patent/US7511031B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1131099A2 (en) | 2001-09-12 |
| US20020127230A1 (en) | 2002-09-12 |
| WO2000041726A9 (en) | 2001-07-12 |
| US7511031B2 (en) | 2009-03-31 |
| JP2002534218A (ja) | 2002-10-15 |
| WO2000041726A3 (en) | 2000-11-02 |
| AU2412800A (en) | 2000-08-01 |
| WO2000041726A2 (en) | 2000-07-20 |
| US20050004510A1 (en) | 2005-01-06 |
| US7767208B2 (en) | 2010-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7767208B2 (en) | Noninvasive vascular therapy | |
| US6602274B1 (en) | Targeted transcutaneous cancer therapy | |
| US20050085455A1 (en) | Photodynamic therapy for local adipocyte reduction | |
| US20030114434A1 (en) | Extended duration light activated cancer therapy | |
| US6344050B1 (en) | Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue | |
| EP1131100B1 (en) | Therapeutic compositions for metabolic bone disorders or bone metastases comprising a photosensitizer and a bisphosphonate | |
| WO2013119957A1 (en) | Weight reduction through inactivation of gastric orexigenic mediator producing cells | |
| MXPA06004289A (en) | Photodynamic therapy for local adipocyte reduction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |